close

Blogs > Cannabis Law Blog

FDA Regulation

Jul 18, 2019

New York City Department of Health Begins Embargoing CBD Food and Beverages

Jul 02, 2019

FDA Emphasizes Its Commitment to “Sound, Science-based Policy” for CBD Products

Under the 2018 Farm Bill, CBD derived from industrial hemp falls outside the Controlled Substances Act, but CBD-infused food and beverages and dietary supplements must still comply with the Food, Drug, and Cosmetic Act and are subject to the authority of the FDA.  » Read More

May 03, 2019

What Cannabis Brand Owners Need to Know About the USPTO’s Recent Guidance on Cannabis Trademarks

On May 2, the United States Patent and Trademark Office (USPTO) issued insightful guidance on its procedures for the examination of trademarks for cannabis-related goods and services. This guidance comes months after the passage of the 2018 Farm Bill, which decriminalized industrial hemp and CBD derived from industrial hemp.» Read More

Feb 19, 2019

The Relationship Between FDA Regulations and Cannabis-Based Drug Patents

As already discussed in my earlier blog post here, patentability of cannabis-related inventions is well-settled, as the USPTO has been granting this type of patents for decades. As the FDA begins approving cannabis-based drug products, patent owners in this market space should pay careful attention to the interplay between FDA regulations and patents.» Read More

Want to receive these blogs in an email? Subscribe here: